A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study

Mohamed Serhana Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada

Athanasios Psihogiosa Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada

Nooh Kabira Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada

A. Brianne Botaa Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada

Salima S. Mithania Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada

David P. Smithb Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada;c Institute of Mental Health Research, University of Ottawa, Ottawa, Canada

David T. Zhua Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada;e Yale School of Public Health, Yale University, New Haven, CT, USA

Devon Greysonf School of Population and Public Health, University of British Columbia, Vancouver, Canada

Sarah Wilsong Health Protection, Public Health Ontario, Toronto, ON, Canada;h Dalla Lana School of Public Health, University of Toronto, Toronto, Canada;i Populations & Public Health Research Program, ICES, Toronto, ON, Canada

Deshayne Felld Department of Pediatrics, Children’s Hospital of Eastern Ontario (CHEO) Research Institute, Ottawa, Canada;j School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada

Karina A. Topk Department of Pediatrics, University of Alberta, Edmonton, AB, Canada;l Departments of Pediatrics and Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada

Julie A. Bettingerm Vaccine Evaluation Center, Department of Pediatrics, BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, Canada

Kumanan Wilsona Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada;j School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada;n Department of Medicine, University of Ottawa, Ottawa, Canada;o O’Neill Institute for National and Global Health Law, Georgetown University;p Bruyère Research Institute, Ottawa, CanadaCorrespondence[email protected]

show all

A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date